Literature DB >> 22682623

Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico.

Julie Dutil1, Jose L Colon-Colon, Jaime L Matta, Rebecca Sutphen, Miguel Echenique.   

Abstract

Mutations in the breast cancer 1, early onset (BRCA1) and breast cancer 2 (BRCA2) genes are responsible for the majority of hereditary breast cancers. Knowledge of the incidence and prevalence of BRCA mutations in a specific population or ethnic group is necessary to provide accurate genetic counseling for breast cancer patients and their families; however, these data have not been gathered in the population of Puerto Rico. We conducted a retrospective study of female breast cancer patients undergoing genetic testing for BRCA mutations in the highest-volume breast surgery practices in San Juan, Puerto Rico. Data collection includes three-generation family cancer history and results from complete BRCA sequencing. A total of six different deleterious mutations were observed, including one mutation in BRCA1 and five mutations in BRCA2. Three recurrent mutations (BRCA1 del exon1-2, BRCA2 4150G>T, and BRCA2 6027del4) account for over 70% of all the BRCA mutations observed in this study population. This study examines for the first time the characteristics of hereditary breast cancer in Puerto Rico and assesses the accuracy of existing genetic risk assessment tools in that population. This data is expected to contribute to providing accurate and efficient tools for the clinical management of hereditary breast cancer in Puerto Rico.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682623      PMCID: PMC3655764          DOI: 10.1016/j.cancergen.2012.04.002

Source DB:  PubMed          Journal:  Cancer Genet


  69 in total

1.  Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer.

Authors:  P de los Rios; E Jack; G Kuperstein; H Lynch; J Lubinski; S A Narod
Journal:  Am J Hum Genet       Date:  2001-02       Impact factor: 11.025

2.  Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research.

Authors:  Esteban González Burchard; Luisa N Borrell; Shweta Choudhry; Mariam Naqvi; Hui-Ju Tsai; Jose R Rodriguez-Santana; Rocio Chapela; Scott D Rogers; Rui Mei; William Rodriguez-Cintron; Jose F Arena; Rick Kittles; Eliseo J Perez-Stable; Elad Ziv; Neil Risch
Journal:  Am J Public Health       Date:  2005-10-27       Impact factor: 9.308

3.  Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.

Authors:  Miguel de la Hoya; Ana Osorio; Javier Godino; Sara Sulleiro; Alicia Tosar; Pedro Perez-Segura; Cristina Fernandez; Raquel Rodríguez; Eduardo Díaz-Rubio; Javier Benítez; Peter Devilee; Trinidad Caldés
Journal:  Int J Cancer       Date:  2002-02-01       Impact factor: 7.396

4.  A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.

Authors:  T Peelen; M van Vliet; A Petrij-Bosch; R Mieremet; C Szabo; A M van den Ouweland; F Hogervorst; R Brohet; M J Ligtenberg; E Teugels; R van der Luijt; A H van der Hout; J J Gille; G Pals; I Jedema; R Olmer; I van Leeuwen; B Newman; M Plandsoen; M van der Est; G Brink; S Hageman; P J Arts; M M Bakker; P Devilee
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

5.  Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.

Authors:  Victor R Grann; Judith S Jacobson; Dustin Thomason; Dawn Hershman; Daniel F Heitjan; Alfred I Neugut
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

6.  High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.

Authors:  Diana Torres; Muhammad Usman Rashid; Fabian Gil; Angela Umana; Giancarlo Ramelli; Jose Fernando Robledo; Mauricio Tawil; Lilian Torregrosa; Ignacio Briceno; Ute Hamann
Journal:  Breast Cancer Res Treat       Date:  2006-11-02       Impact factor: 4.872

7.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

8.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

9.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry.

Authors:  Allison W Kurian; Gail D Gong; Esther M John; Alexander Miron; Anna Felberg; Amanda I Phipps; Dee W West; Alice S Whittemore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

View more
  19 in total

Review 1.  Genetic counseling for hereditary breast and ovarian cancer among Puerto Rican women living in the United States.

Authors:  Courtney L Scherr; Elsa Vasquez; Gwendolyn P Quinn; Susan T Vadaparampil
Journal:  Rev Recent Clin Trials       Date:  2014

2.  Genomic Disparities in Breast Cancer Among Latinas.

Authors:  Filipa Lynce; Kristi D Graves; Lina Jandorf; Charite Ricker; Eida Castro; Laura Moreno; Bianca Augusto; Laura Fejerman; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

3.  Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.

Authors:  Xavier Gabaldó Barrios; Mª Desamparados Sarabia Meseguer; Miguel Marín Vera; Ana Isabel Sánchez Bermúdez; José Antonio Macías Cerrolaza; Pilar Sánchez Henarejos; Marta Zafra Poves; Mª Rosario García Hernández; Encarna Cuevas Tortosa; Ángeles Aliaga Baño; Verónica Castillo Guardiola; Pedro Martínez Hernández; Isabel Tovar Zapata; Enrique Martínez Barba; Francisco Ayala de la Peña; José Luis Alonso Romero; José Antonio Noguera Velasco; Francisco Ruiz Espejo
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

4.  Identification of a novel breast cancer-causing mutation in the BRCA1 gene by targeted next generation sequencing: A case report.

Authors:  Yanyan Wang; Da Jiang; Qiang Zhao; Hui Huang; Xue Zhang; Yanzhi Cui; Jiayin Liu; Jing Wu; Keke Lin; Weixi Chen; Jiale Xiang; Hui Jin; Zhiyu Peng; Santasree Banerjee
Journal:  Oncol Lett       Date:  2018-07-12       Impact factor: 2.967

Review 5.  Genetic Cancer Risk Assessment for Breast Cancer in Latin America.

Authors:  Yanin Chavarri-Guerra; Kathleen Reilly Blazer; Jeffrey Nelson Weitzel
Journal:  Rev Invest Clin       Date:  2017 Mar-Apr       Impact factor: 1.451

6.  Improving cancer clinical research and trials with Hispanic populations: training and outreach efforts between Moffitt Cancer Center and the Ponce School of Medicine.

Authors:  Gwendolyn P Quinn
Journal:  Rev Recent Clin Trials       Date:  2014

7.  When a Common Language Is Not Enough: Transcreating Cancer 101 for Communities in Puerto Rico.

Authors:  Y M Rivera; H Vélez; J Canales; J C Jiménez; L Moreno; J Torres; S T Vadaparampil; T Muñoz-Antonia; G P Quinn
Journal:  J Cancer Educ       Date:  2016-12       Impact factor: 2.037

Review 8.  Clinical Cancer Genetics Disparities among Latinos.

Authors:  Marcia Cruz-Correa; Julyann Pérez-Mayoral; Julie Dutil; Miguel Echenique; Rafael Mosquera; Keila Rivera-Román; Sharee Umpierre; Segundo Rodriguez-Quilichini; Maria Gonzalez-Pons; Myrta I Olivera; Sherly Pardo
Journal:  J Genet Couns       Date:  2016-12-12       Impact factor: 2.537

9.  The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.

Authors:  Julie Dutil; Volha A Golubeva; Alba L Pacheco-Torres; Hector J Diaz-Zabala; Jaime L Matta; Alvaro N Monteiro
Journal:  Breast Cancer Res Treat       Date:  2015-11-12       Impact factor: 4.872

10.  Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2.

Authors:  Michael Dean; Joseph Boland; Meredith Yeager; Kate M Im; Lisa Garland; Maria Rodriguez-Herrera; Mylen Perez; Jason Mitchell; David Roberson; Kristine Jones; Hyo Jung Lee; Rebecca Eggebeen; Julie Sawitzke; Sara Bass; Xijun Zhang; Vivian Robles; Celia Hollis; Claudia Barajas; Edna Rath; Candy Arentz; Jose A Figueroa; Diane D Nguyen; Zeina Nahleh
Journal:  Gigascience       Date:  2015-11-04       Impact factor: 6.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.